Calithera Biosciences Top Management

CALADelisted Stock  USD 0.05  0.00  0.00%   
Calithera Biosciences employs about 8 people. The company is managed by 8 executives with a total tenure of roughly 46 years, averaging almost 5.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Calithera Biosciences' management performance can provide insight into the company performance.
Susan Molineaux  CEO
Co-Founder, CEO and President and Director
Stephanie Wong  President
Chief Accounting Officer, Vice President - Finance
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Calithera Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.5629) % which means that it has lost $0.5629 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1414) %, meaning that it created substantial loss on money invested by shareholders. Calithera Biosciences' management efficiency ratios could be used to measure how well Calithera Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Calithera Biosciences Workforce Comparison

Calithera Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,422. Calithera Biosciences maintains roughly 8.0 in number of employees contributing less than 1% to equities under Health Care industry.

Calithera Biosciences Notable Stakeholders

A Calithera Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Calithera Biosciences often face trade-offs trying to please all of them. Calithera Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Calithera Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Susan MolineauxCo-Founder, CEO and President and DirectorProfile
Stephanie WongChief Accounting Officer, Vice President - FinanceProfile
Eric SjogrenSr. VP of Drug DiscoveryProfile
Christopher MolineauxSr. VP of Devel.Profile
Allison DillonVP StrategyProfile
Susan DemoVP OperationsProfile
Frank ParlatiVP ResearchProfile
Emil MDChief OfficerProfile

About Calithera Biosciences Management Performance

The success or failure of an entity such as Calithera Biosciences often depends on how effective the management is. Calithera Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Calithera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Calithera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. Calithera Biosci operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.
Please note, the presentation of Calithera Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Calithera Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Calithera Biosciences' management manipulating its earnings.

Calithera Biosciences Workforce Analysis

Traditionally, organizations such as Calithera Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Calithera Biosciences within its industry.

Calithera Biosciences Manpower Efficiency

Return on Calithera Biosciences Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee5M
Net Loss Per Executive5M
Working Capital Per Employee2.4M
Working Capital Per Executive2.4M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Calithera Pink Sheet

If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing